RespireRx Pharmaceuticals Inc (RSPI)

[gfp927z]

Aiming, One solution to your dilemma is to just hold a sensible amount of Cortex and let it ride. Balance, diversification, moderation - that's the key to success (and survival) in this sector IMO.

BTW, After listening to a recent PTIE presentation, I've really soured on that company (it was up 7% today, figures) :o) Their foray into cancer looks ridiculous, and Oxytrex's future doesn't look all that great. Barbier really sounded like an idiot when he tried to explain their cancer program. It's obvious that he knows very little about the armed MAB area. Remoxy is the only thing I like in their pipeline, plus the 2nd abuse resistant pain program. To participate with those I'm going to go with Durect, the creator/licensor of that technology. Durect also has numerous other promising programs (especially long acting Bupivacaine which just got a nice partnering deal).